Literature DB >> 20934612

Medication and falls: risk and optimization.

Nichola Boyle1, Vasi Naganathan, Robert G Cumming.   

Abstract

The association between drugs and falls has been widely studied in the past 3 decades, with increasingly robust evidence of a causal link. Both specific classes of drugs and the total number of drugs taken are associated with falls. This review examines some of the reasons why older people are at greater risk of drug-related adverse events such as falls. We discuss the role of drugs in general and polypharmacy (the concurrent use of multiple drugs) on the risk of falling, with a focus on community-dwelling older people. We critically appraise the evidence that specific classes of drugs, such as benzodiazepines and antidepressants, increase the risk of falling and that falls can be prevented through interventions that target medications.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934612     DOI: 10.1016/j.cger.2010.06.007

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  23 in total

1.  Medication-related fall incidents in an older, ambulant population: the B-PROOF study.

Authors:  Annelies C Ham; Karin M A Swart; Anke W Enneman; Suzanne C van Dijk; Sadaf Oliai Araghi; Janneke P van Wijngaarden; Nikita L van der Zwaluw; Elske M Brouwer-Brolsma; Rosalie A M Dhonukshe-Rutten; Natasja M van Schoor; Tischa J M van der Cammen; Paul Lips; Lisette C P G M de Groot; André G Uitterlinden; Renger F Witkamp; Bruno H Stricker; Nathalie van der Velde
Journal:  Drugs Aging       Date:  2014-12       Impact factor: 3.923

Review 2.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

3.  Fall-related risk factors and heel quantitative ultrasound in the assessment of hip fracture risk: a 10-year follow-up of a nationally representative adult population sample.

Authors:  M Kauppi; S Stenholm; O Impivaara; J Mäki; M Heliövaara; A Jula
Journal:  Osteoporos Int       Date:  2014-06       Impact factor: 4.507

4.  Beta-blocker use and fall risk in older individuals: Original results from two studies with meta-analysis.

Authors:  Annelies C Ham; Suzanne C van Dijk; Karin M A Swart; Anke W Enneman; Nikita L van der Zwaluw; Elske M Brouwer-Brolsma; Natasja M van Schoor; M Carola Zillikens; Paul Lips; Lisette C P G M de Groot; Albert Hofman; Renger F Witkamp; André G Uitterlinden; Bruno H Stricker; Nathalie van der Velde
Journal:  Br J Clin Pharmacol       Date:  2017-07-04       Impact factor: 4.335

5.  Accidental falls in home care hematological patients.

Authors:  A Tendas; L Cupelli; M M Trawinska; L Lentini; M Giovannini; L Scaramucci; M Palombi; G A Brunetti; C Cartoni; P de Fabritiis; P Niscola; F Mandelli
Journal:  Support Care Cancer       Date:  2013-05-03       Impact factor: 3.603

6.  Helping pharmacists to reduce fall risk in long-term care: A clinical tool to facilitate the medication review process.

Authors:  Carlos H Rojas-Fernandez; Nicole Seymour; Susan G Brown
Journal:  Can Pharm J (Ott)       Date:  2014-05

7.  Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Majda Azermai; Luc Van Bortel; Mirko Petrovic; Robert R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2011-12-22       Impact factor: 2.953

8.  Therapeutic application of melatonin in mild cognitive impairment.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Analía M Furio; Luis I Brusco
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  The direct costs of fatal and non-fatal falls among older adults - United States.

Authors:  Elizabeth R Burns; Judy A Stevens; Robin Lee
Journal:  J Safety Res       Date:  2016-05-28

Review 10.  Adverse drug events as a cause of hospitalization in older adults.

Authors:  Fabio Salvi; Annalisa Marchetti; Federica D'Angelo; Massimo Boemi; Fabrizia Lattanzio; Antonio Cherubini
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.